Observational studyTargeted oncology2021

Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).

Massimo Aglietta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.